Jonathan Y. Gabor
Concordia Hospital
3 Papers
Jonathan Y. Gabor is an academic researcher from Concordia Hospital. The author has contributed to research in topics: Blood pressure & Risk assessment. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children
Kara Nerenberg,Kelly B. Zarnke,Alexander A. Leung,Kaberi Dasgupta,Sonia Butalia,Kerry McBrien,Kevin C. Harris,Meranda Nakhla,Lyne Cloutier,Mark Gelfer,Maxime Lamarre-Cliche,Alain Milot,Peter Bolli,Guy Tremblay,Donna McLean,Raj Padwal,Karen C. Tran,Steven A. Grover,Simon W. Rabkin,Gordon W. Moe,Jonathan G. Howlett,Patrice Lindsay,Michael D. Hill,Mike Sharma,Thalia S. Field,Theodore Wein,Ashkan Shoamanesh,George K. Dresser,Pavel Hamet,Robert J. Herman,Ellen Burgess,Steven E. Gryn,Jean Grégoire,Richard Lewanczuk,Luc Poirier,Tavis S. Campbell,Ross D. Feldman,Kim L. Lavoie,Ross T. Tsuyuki,George Honos,Ally P.H. Prebtani,Gregory A. Kline,Ernesto L. Schiffrin,Andrew C. Don-Wauchope,Sheldon W. Tobe,Richard E. Gilbert,Lawrence A. Leiter,Charlotte Jones,Vincent Woo,Robert A. Hegele,Peter Selby,Andrew L. Pipe,Philip A. McFarlane,Paul Oh,Milan Gupta,Simon L. Bacon,Janusz Kaczorowski,Luc Trudeau,Norman R.C. Campbell,Swapnil Hiremath,Michael Roerecke,JoAnne Arcand,Marcel Ruzicka,G. V. Ramesh Prasad,Michel Vallée,Cedric Edwards,Praveena Sivapalan,S. Brian Penner,Anne Fournier,Geneviève Benoit,Janusz Feber,Janis M. Dionne,Laura A. Magee,Alexander G. Logan,Anne-Marie Côté,Evelyne Rey,Tabassum Firoz,Laura M. Kuyper,Jonathan Y. Gabor,Raymond R. Townsend,Doreen M. Rabi,Doreen M. Rabi,Stella S. Daskalopoulou +82 more
TL;DR: All individuals with hypertension should have an assessment of global cardiovascular risk to promote health behaviours that lower blood pressure, and an angiotensin receptor-neprilysin inhibitor combination should be used in place of either an ang Elliotensin-converting enzyme inhibitor or angiotENSin receptor blocker in individuals with heart failure.
573
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.
Doreen M. Rabi,Kerry McBrien,Ruth Sapir-Pichhadze,Meranda Nakhla,Sofia B. Ahmed,Sandra M. Dumanski,Sonia Butalia,Alexander A. Leung,Kevin C. Harris,Lyne Cloutier,Kelly B. Zarnke,Marcel Ruzicka,Swapnil Hiremath,Ross D. Feldman,Sheldon W. Tobe,Tavis S. Campbell,Simon L. Bacon,Kara Nerenberg,George K. Dresser,Anne Fournier,Ellen Burgess,Patrice Lindsay,Simon W. Rabkin,Ally P.H. Prebtani,Steven A. Grover,George Honos,Jeffrey E. Alfonsi,JoAnne Arcand,François Audibert,Geneviève Benoit,Jesse Bittman,Peter Bolli,Anne-Marie Côté,Janis M. Dionne,Andrew C. Don-Wauchope,Cedric Edwards,Tabassum Firoz,Jonathan Y. Gabor,Richard E. Gilbert,Jean Grégoire,Steven E. Gryn,Milan Gupta,Fady Hannah-Shmouni,Robert A. Hegele,Robert J. Herman,Michael D. Hill,Jonathan G. Howlett,Gregory L. Hundemer,Charlotte Jones,Janusz Kaczorowski,Nadia A. Khan,Laura M. Kuyper,Maxime Lamarre-Cliche,Kim L. Lavoie,Lawrence A. Leiter,Richard Lewanczuk,Alexander G. Logan,Laura A. Magee,Birinder K. Mangat,Philip A. McFarlane,Donna McLean,André Michaud,Alain Milot,Gordon W. Moe,S. Brian Penner,Andrew L. Pipe,Alexandre Y Poppe,Evelyne Rey,Michael Roerecke,Ernesto L. Schiffrin,Peter Selby,Mike Sharma,Ashkan Shoamanesh,Praveena Sivapalan,Raymond R. Townsend,Karen Tran,Luc Trudeau,Ross T. Tsuyuki,Michel Vallée,Vincent Woo,Alan Bell,Stella S. Daskalopoulou +81 more
TL;DR: The 2020 guidelines include new guidance on themanagement of resistant hypertension and the management of hypertension in women planning pregnancy.
483
Hypertension Canada's 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension
Swapnil Hiremath,Ruth Sapir-Pichhadze,Meranda Nakhla,Jonathan Y. Gabor,Nadia A. Khan,Laura M. Kuyper,Marcel Ruzicka,Sheldon W. Tobe,Karen Tran,Doreen M. Rabi,Stella S. Daskalopoulou +10 more
TL;DR: Hypertension Canada's inaugural evidence-based recommendations for the diagnosis and management of resistant hypertension recommend that patients with blood pressure above target, despite use of 3 or more blood pressure-lowering drugs at optimal doses, be identified as those with apparent resistant hypertension.